CLSD - Potencial Short
Potencial Short
News - CLSD-News-Wired News – Clearside BioMedical Reported Positive Top-line Results from Phase-3 Trial Assessing CLS-TA in Macular Edema Associated with Non-infectious Uveitis
Volumen 3.5M, Float 18.42M, Avg Vol (10 day) 3.07M, Avg Vol (3 month) 426.32k, NasdaqGM, Healthcare-Biotechnology
Entry 14.25, Stop Loss 14.90, Take profit 12.50, 1D Still green candle# Entry 1m timeframe#Broke trend line#BreakDown#Stock made in 2 days 130%-News (4 News in 2 days-incredible)
Be ready if market make something unpredictable. Stay with your position, carefully!!!
News - CLSD-News-Wired News – Clearside BioMedical Reported Positive Top-line Results from Phase-3 Trial Assessing CLS-TA in Macular Edema Associated with Non-infectious Uveitis
Volumen 3.5M, Float 18.42M, Avg Vol (10 day) 3.07M, Avg Vol (3 month) 426.32k, NasdaqGM, Healthcare-Biotechnology
Entry 14.25, Stop Loss 14.90, Take profit 12.50, 1D Still green candle# Entry 1m timeframe#Broke trend line#BreakDown#Stock made in 2 days 130%-News (4 News in 2 days-incredible)
Be ready if market make something unpredictable. Stay with your position, carefully!!!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.